Form 4: Intest Corp CEO Richard N. Grant, Jr. Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Richard N. Grant, Jr., President and CEO of Intest Corp, sold shares of common stock to satisfy tax withholding obligations related to vesting restricted stock, as reported in a recent SEC Form 4 filing.
Summary
- Richard N. Grant, Jr., the President and CEO of Intest Corp, reported the sale of company stock in a Form 4 filing with the SEC.
- The transactions occurred on March 10 and March 11, 2025.
- A total of 2,688 shares were sold on March 10 at a weighted average price of $7.48, and 1,184 shares were sold on March 11 at a weighted average price of $7.57.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2023.
- The purpose of the sales was to cover tax withholding obligations associated with the vesting of restricted stock.
- Following these transactions, Mr. Grant directly owns 161,057 shares of Intest Corp common stock.
- Mr. Grant also holds employee stock options for a total of 185,216 shares at exercise prices ranging from $9.76 to $16.06.
Sentiment
Score: 6
Explanation: Neutral sentiment. The stock sales are for tax purposes under a pre-arranged plan, which is a common practice. However, any insider selling can create some uncertainty.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating they were planned in advance and not based on current market information.
- The CEO still holds a significant number of shares and options, suggesting continued alignment with the company's success.
Negatives
- The sale of shares, even for tax purposes, could be perceived negatively by some investors.
Risks
- Further sales by the CEO, even under the 10b5-1 plan, could put downward pressure on the stock price.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Insider sales are common, especially to cover tax obligations. The use of a 10b5-1 plan is a standard practice to avoid accusations of trading on inside information. Investors often monitor insider transactions for signals about a company's prospects, but tax-related sales are generally viewed as less informative.
Comparison to Industry Standards
- Comparing Intest Corp's insider trading activity to companies like Teradyne or Advantest, which also operate in the semiconductor testing equipment industry, would provide a better understanding of whether these transactions are typical.
- For example, if executives at Teradyne or Advantest are also selling shares under similar 10b5-1 plans to cover tax obligations, it would suggest that this is a common practice in the industry.
- Analyzing the frequency and size of insider transactions relative to the company's market capitalization can also provide context.
Stakeholder Impact
- The stock sales could have a minor negative impact on shareholder sentiment in the short term.
Key Dates
| Date | Description |
|---|---|
| December 8, 2023 | Date the Rule 10b5-1 trading plan was adopted. |
| March 05, 2024 | First vesting date of employee stock option with exercise price of $11.33. |
| March 08, 2024 | First vesting date of employee stock option with exercise price of $16.06. |
| March 09, 2023 | First vesting date of employee stock option with exercise price of $9.76. |
| March 10, 2025 | Date of first stock sale (2,688 shares). |
| March 11, 2025 | Date of second stock sale (1,184 shares). |
| March 12, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.